Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer

Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women

2003 • 1,839 citations

Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

1993 • 1,018 citations

Physiological Action of Progesterone in Target Tissues*

1997 • 912 citations

Classification and pharmacology of progestins

2003 • 712 citations

Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone

2003 • 517 citations

BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells

1999 • 494 citations

Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone

2001 • 474 citations

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

1999 • 421 citations

Physiological Action of Progesterone in Target Tissues

1997 • 393 citations

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N‐EPIC cohort

2004 • 388 citations

Pharmacological profile of progestins

2004 • 360 citations

Androgen receptor expression in human tissues: an immunohistochemical study.

1991 • 310 citations

Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications

2005 • 304 citations

Dynamics of Intracellular Movement and Nucleocytoplasmic Recycling of the Ligand-Activated Androgen Receptor in Living Cells

2000 • 283 citations

Modification of BRCA1-Associated Breast Cancer Risk by the Polymorphic Androgen-Receptor CAG Repeat

1999 • 253 citations

Androgens induce divergent proliferative responses in human breast cancer cell lines

1995 • 239 citations

Androgen receptors frequently are expressed in breast carcinomas

2003 • 237 citations

Androgen Receptor Expression in Estrogen Receptor-Negative Breast Cancer Immunohistochemical, Clinical, and Prognostic Associations

2003 • 217 citations

Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe

2004 • 217 citations

BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

2001 • 212 citations

Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women

2004 • 204 citations

Distinguishing Androgen Receptor Agonists and Antagonists: Distinct Mechanisms of Activation by Medroxyprogesterone Acetate and Dihydrotestosterone

1999 • 203 citations

Interactions between androgen and estrogen receptors and the effects on their transactivational properties

2000 • 197 citations

Testosterone inhibits estrogen‐induced mammary epithelial proliferation and suppresses estrogen receptor expression

2000 • 190 citations

Widespread tissue distribution of steroid sulfatase, 3β-hydroxysteroid dehydrogenase/Δ5-Δ4isomerase(3β-HSD), 17β-HSD5α-reductase and aromatase activities in the rhesus monkey

1994 • 189 citations

Androgen Receptor Expression in Estrogen Receptor–Negative Breast Cancer

2003 • 189 citations

Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment

2005 • 187 citations

Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.

2000 • 170 citations

Breast cancer risk with postmenopausal hormonal treatment

2005 • 168 citations

Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques

1996 • 167 citations

Roles of androgens in the development, growth, and carcinogenesis of the mammary gland

2002 • 162 citations

Therapeutic targeting in the estrogen receptor hormonal pathway

2004 • 161 citations

Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells

2000 • 154 citations

Abnormal Mammary Gland Development and Growth Retardation in Female Mice and MCF7 Breast Cancer Cells Lacking Androgen Receptor

2003 • 145 citations

The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters

1996 • 142 citations

Improved measurement of androgen receptors in human breast cancer.

1989 • 141 citations

Estrogen receptor transcription and transactivation Estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action

2000 • 138 citations

Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 Coactivator Recruitment by Activation Function 2

2001 • 137 citations

Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells

1999 • 132 citations

Progestins and progesterone in hormone replacement therapy and the risk of breast cancer

2005 • 131 citations

Progesterone receptors in mammary gland development and tumorigenesis.

2003 • 129 citations

Evaluation of Tamoxifen Doses With and Without Fluoxymesterone in Advanced Breast Cancer

1983 • 129 citations

Role of the androgen receptor in human breast cancer.

1998 • 119 citations

An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk

2005 • 119 citations

No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer

1999 • 118 citations

Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer

2000 • 111 citations

Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells

1999 • 108 citations

Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in routinely processed, paraffin-embedded human tissues after microwave pre-treatment.

1994 • 104 citations

Extragonadal synthesis of sex steroids: intracrinology.

2003 • 104 citations

Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer.

1980 • 103 citations

Down-Regulation of Estrogen Receptors by Androgens in the ZR-75-1 Human Breast Cancer Cell Line*

1989 • 103 citations

Testosterone and 5α-dihydrotestosterone inhibitin vitrogrowth of human breast cancer cell lines

2002 • 102 citations

Combination hormonal therapy with tamoxifen plus fluoxymesteroneversus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

1991 • 100 citations

Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density

2003 • 95 citations

The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.

2002 • 93 citations

Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population.

2001 • 92 citations

Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys

2006 • 91 citations

Androgens and mammary growth and neoplasia

2002 • 91 citations

Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer

2000 • 89 citations

Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma

2005 • 89 citations

Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression.

1995 • 87 citations

Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones

2004 • 86 citations

Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.

2003 • 85 citations

High frequency of skewed X inactivation in young breast cancer patients

2002 • 83 citations

A contemporary understanding of progesterone receptor function

2004 • 81 citations

Androgen Receptor Exon 1 CAG Repeat Length and Breast Cancer in Women Before Age Forty Years

1999 • 80 citations

Androgens Down-Regulate bcl-2 Protooncogene Expression in ZR-75-1 Human Breast Cancer Cells**This work was supported by a grant from the Canadian Breast Cancer Research Initiative (to C.L.), scholarships from the Fonds de la Recherche en Santé du Québec (to C.L. and J.L.). Additional financial support was provided by Endorecherche.

1999 • 79 citations

Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women

2002 • 79 citations

Androgen sensitivity of the new human breast cancer cell line MFM-223.

1991 • 78 citations

Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer

2006 • 77 citations

Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis

2005 • 76 citations

Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1)

2004 • 75 citations

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers

2001 • 74 citations

Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice.

1991 • 73 citations

Decreased Androgen Receptor Levels and Receptor Function in Breast Cancer Contribute to the Failure of Response to Medroxyprogesterone Acetate

2005 • 71 citations

Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer

1996 • 70 citations

A critique of the Women’s Health Initiative hormone therapy study

2005 • 68 citations

The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells

2005 • 66 citations

Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.

2003 • 63 citations

Serum Estradiol-Binding Profiles in Postmenopausal Women Undergoing Three Common Estrogen Replacement Therapies

2000 • 61 citations

Risk of breast cancer with progestins: critical assessment of current data

2003 • 61 citations

Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women

2002 • 60 citations

Inhibition of cell cycle kinetics and proliferation by the androgen 5 alpha-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16' alpha-chloro-3',17 beta-dihydroxy-estra-1',3',5'-(10')triene-7' alpha-yl] undecanamide in human breast cancer ZR-75-1 cells.

1991 • 59 citations

Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor

1993 • 58 citations

Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer

2001 • 57 citations

Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status

2003 • 54 citations

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

2004 • 47 citations

A critique of Women’s Health Initiative Studies (2002-2006)

2007 • 47 citations

Hormone replacement therapy and risk of breast cancer: the role of progestins

2003 • 42 citations

Relationship between the expression of various markers and prognostic factors in breast cancer

2005 • 41 citations

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

2006 • 41 citations

Pregnancy, progesterone and progestins in relation to breast cancer risk

2005 • 40 citations

Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype

2002 • 40 citations

Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer

2004 • 39 citations

Androgen receptors, serum androgen levels and survival of breast cancer patients

1990 • 37 citations

Androgens and androgen receptor: do they play a role in breast cancer?

2001 • 36 citations

Polymorphism in the Androgen Receptor and Mammographic Density in Women Taking and Not Taking Estrogen and Progestin Therapy

2004 • 36 citations

Association of kallikrein expression in nipple aspirate fluid with breast cancer risk

2003 • 36 citations

Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines.

2003 • 35 citations

Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.

2002 • 33 citations

Hormone replacement therapy and risk of breast cancer: the role of progestins

2003 • 30 citations

Androgen Receptor and Prostate-Specific Antigen Gene Polymorphisms and Breast Cancer in African-American Women

2005 • 30 citations

Androgens Down-Regulate bcl-2 Protooncogene Expression in ZR-75-1 Human Breast Cancer Cells

1999 • 27 citations

Microsatellite profile in hormonal receptor genes associated with breast cancer

2005 • 25 citations

An in vitro long-term culture model for normal human mammary gland: expression and regulation of steroid receptors

2003 • 25 citations

Short Tandem Repeat Polymorphism and Cancer Risk: Influence of Laboratory Analysis on Epidemiologic Findings

2004 • 23 citations

The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer

2000 • 21 citations

Postmenopausal hormone therapy and the risk of breast cancer: the view of an epidemiologist

2004 • 20 citations

Postmenopausal hormone therapy and the risk of breast cancer

2004 • 16 citations

Lessons to be learned from clinical studies on hormones and the breast

2004 • 7 citations

Deleted Work

1955 • 0 citations